2 POSTS
Erica Rex writes about science, environment, mental health, climate,
and the forces shaping all of them. She’s written for
The New York
Times, Scientific American, The Times (UK) among many other
publications, and is the recipient of a National Magazine Award. She
was a subject in one of the first clinical trials using psilocybin to
treat cancer related depression in 2012. Her book-in-progress traces
the story of psychedelics through the lens of her quest to heal from
childhood trauma. Ms. Rex’s unique perspective shows how psychedelic
medicine can provide a pathway out of trauma, a light at the end of a
very long tunnel, but it is not without risks.